Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio
Updated on: February 18,2024
Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio
Updated on:February 18,2024
